← Eichor
Study identifier: NCT07691827 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Maternal Inheritance of a Pathogenic MT-ND1 Mutation Causes Mitochondrial Dysfunction and Spermatogenic Failure in Men

Condition: Azoospermia, Nonobstructive · Cryptozoospermia  ·  Sponsor: The Third Affiliated Hospital of Guangzhou Medical University

PhaseN/A
Planned participants1200
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersNo

About this study

Idiopathic non-obstructive azoospermia and cryptozoospermia are severe forms of male infertility in which sperm production is absent or extremely low and the cause is often unknown. This retrospective observational study examined whether mitochondrial DNA variants, particularly the MT-ND1 m.3700G\>A variant, are associated with impaired sperm production in Chinese men. Existing clinical records and available biospecimens from affected men, eligible family members, and fertile controls were analyzed to assess familial inheritance patterns, the frequency of the variant, and its association with infertility phenotypes. No study-related treatment or intervention was provided to human participants.

This description comes directly from the study's public registry record.

Talk to the study team

Chen  ·  86-15918822529  ·  15918822529@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

The Third Affiliated Hospital of Guangzhou Medical UniversityGuangzhou, Guangdong, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07691827